Switch to:
More From Other Websites
The Diabetes Price War Claims Casualties Sep 29 2016
Understanding diabetes in the developing world Sep 29 2016
Looking Abroad for Quality Bargains Sep 28 2016
ETF’s with exposure to Sanofi : September 27, 2016 Sep 27 2016
The Zacks Analyst Blog Highlights: Teva Pharmaceutical Industries, Intel, Sanofi, Alphabet and... Sep 27 2016
[$$] Corporate-Bond Buying Attracts Doubts as Growth Tool for Europe Sep 27 2016
Regeneron-Sanofi Could Beat Pfizer, Roche, AstraZeneca On Eczema Sep 26 2016
Regeneron, Sanofi Skin Disease Drug Under Priority Review Sep 26 2016
Sanofi gets $43 mln U.S. funding to spur Zika vaccine development Sep 26 2016
Pfizer: Split Decision Sep 26 2016
BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika ​ Sep 26 2016
Sanofi and Regeneron Announce Dupilumab Biologics License Application Accepted for Priority Review... Sep 26 2016
The Internet of Medical Things: 6 Stocks in Focus Sep 26 2016
​FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme Sep 26 2016
Sanofi may win U.S. approval of $3 billion eczema drug by March Sep 26 2016
Sanofi may win U.S. approval of $3 bln eczema drug by March Sep 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)